Home > Insider Trading > Vbi Vaccines Inc. (Old Filings)

Vbi Vaccines Inc. (Old Filings) (VBIV)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 16

Hedge Fund and Insider Trading News: Eddie Lampert, Steven Cohen, Synergy CHC Corp (SNYR), Marijuana Company Of America Inc (MCOA), Cracker Barrel Old Country Store, Inc. (CBRL), and More

Much has changed in retail over the past 16 years. Amazon has risen and towering giants like Toys R Us have fallen.

Keep Reading →

December 19th, 2018 - Hedge Funds Insider Trading

13D Filing: Perceptive Advisors and VBI Vaccines, Inc. (VBIV)

for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a...

Keep Reading →

October 31st, 2017 - Hedge Funds

13D Filing: Opko Health, Inc. and Vbi Vaccines Inc. (NASDAQ:VBIV)

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...

Keep Reading →

April 4th, 2017 - Hedge Funds

VBI Vaccines, Inc. (VBIV) Gets European Support For Pivotal Phase III Sci-B-Vac Trial

Risks in biotech investment tend to increase as a young company gets closer and closer to its first FDA approval.

Keep Reading →

February 14th, 2017 - News Stock Analysis

$23.6M Investment From 2015's Top Performing Hedge Fund Makes VBI Vaccines, Inc. (VBIV) Even More Undervalued

One would think that a hepatitis B vaccine with 100% efficacy, negligible safety issues, and mountains of clinical data already supporting it would be valued at a little bit more than $70 million.

Keep Reading →

December 6th, 2016 - Hedge Funds News Stock Analysis